Application Sponsors
NDA 012402 | PROCTER AND GAMBLE | |
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | EQ 180MG BASE/VIAL | 0 | IVADANTIN | NITROFURANTOIN SODIUM |
FDA Submissions
TYPE 2; Type 2 - New Active Ingredient | ORIG | 1 | AP | 1960-09-15 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 15 | AP | 1979-06-06 | STANDARD |
LABELING; Labeling | SUPPL | 16 | AP | 1979-06-06 | STANDARD |
LABELING; Labeling | SUPPL | 17 | AP | 1979-07-13 | STANDARD |
LABELING; Labeling | SUPPL | 19 | AP | 1982-10-18 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 21 | AP | 1982-04-13 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 0 |
SUPPL | 15 | Null | 0 |
SUPPL | 16 | Null | 0 |
SUPPL | 17 | Null | 0 |
SUPPL | 19 | Null | 0 |
SUPPL | 21 | Null | 0 |
CDER Filings
PROCTER AND GAMBLE
cder:Array
(
[0] => Array
(
[ApplNo] => 12402
[companyName] => PROCTER AND GAMBLE
[docInserts] => ["",""]
[products] => [{"drugName":"IVADANTIN","activeIngredients":"NITROFURANTOIN SODIUM","strength":"EQ 180MG BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"IVADANTIN","submission":"NITROFURANTOIN SODIUM","actionType":"EQ 180MG BASE\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)